How I Approach the Management of Eosinophilic Esophagitis in Adults

1Division of Gastroenterology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA Correspondence: I Hirano, MD, Division of Gastroenterology, Northwestern University Feinberg School of Medicine, 676 North Saint Clair, Suite 1400, Chicago, Illinois 60611, USA. E-mail: [email protected] Guarantor of the article: Ikuo Hirano, MD. Specific author contributions: Ikuo Hirano drafted and approved the final manuscript. Financial support: None. Potential competing interests: IH is the consultant for pharmaceutical companies developing therapeutics for eosinophilic esophagitis but none are discussed in this paper. IH is the consultant for Shire, Regeneron, Receptos, Adare.